Cancer Distribution Pattern in the City of Kenitra, Morocco (2017-2022): A Pathology-Based Study
Radia El Gui1, Soumia Ed-Day1, Azzouz Haddan2
1Biology & Health Laboratory, Faculty of Science, Ibn Tofail University, Kenitra, Morocco.
Asian Pacific Journal of Cancer Prevention : APJCP
|July 29, 2026
Summary
This study details cancer incidence in Kenitra, Morocco, revealing high rates of prostate, bladder, and skin cancers. Further research is recommended to understand causes and develop prevention strategies for these prevalent cancers.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Cancer surveillance is crucial for effective prevention policies.
- Morocco lacks comprehensive cancer data, with only two population-based registries.
- This study addresses the data gap by examining cancer incidence in Kenitra.
Purpose of the Study:
- To describe the pattern of cancer incidence rates in Kenitra, Morocco.
- To provide baseline data for future cancer control and prevention efforts.
- To identify the most common cancer types in the region.
Main Methods:
- A retrospective, descriptive study of newly diagnosed cancers from 2017-2022.
- Data collected from public and private pathology laboratories in Kenitra.
- Analysis included frequencies, percentages, crude incidence rates, and age-standardized rates (ASR).
Main Results:
- 2,682 cancer cases were recorded; 57.23% males, 42.77% females.
- The overall age-standardized rate (ASR) was 283 per 100,000 population.
- Leading male cancers: prostate (34.31%), bladder (19.27%), skin (13.54%). Leading female cancers: breast (27%), skin (15%), cervix (8%).
Conclusions:
- This is the first study on cancer occurrence in Kenitra.
- High incidence rates of bladder and skin cancer require further investigation.
- Epidemiological studies are needed to identify etiological factors and inform prevention strategies.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.